AKT1 and neoplasm: IL-8 treatment improved the resistance of tumor cells to apoptosis with the increased level of T-LAK cell-originated protein kinase (TOPK) by activating the PI3K-Akt and Ras-Raf-Mek-Erk signaling pathways [48].